# In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma

> **NCT02740049** · EARLY_PHASE1 · COMPLETED · sponsor: **Imperial College London** · enrollment: 9 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** VR588

## Key facts

- **NCT ID:** NCT02740049
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-27
- **Primary completion:** 2016-10-19
- **Final completion:** 2016-10-19
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2019-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02740049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02740049, "In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02740049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*